Literature DB >> 22190152

Kidney Disease in HIV-Infected Persons.

Robert C Kalayjian1.   

Abstract

Kidney disease is more prevalent among persons living with HIV, and may arise from a combination of comorbidities, co-infections, and medication-associated toxicities. Additional effects of HIV-1 viral replication, immunodeficiency and genetic factors also contribute to kidney disease. As is true in the general population, persons of African descent exhibit a disproportionate risk for severe kidney disease. Antiretroviral therapy (ART) modifies the natural history of HIV-associated nephropathy (HIVAN), and renal benefits of ART may not be limited to persons with HIVAN. Robust associations between proteinuria and cardiovascular disease imply that common mechanisms of vascular endothelial dysfunction may contribute to both processes.

Entities:  

Year:  2012        PMID: 22190152     DOI: 10.1007/s11908-011-0228-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  91 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Renal dysfunction among HIV-infected patients starting antiretroviral therapy.

Authors:  Leonard Msango; Jennifer A Downs; Samuel E Kalluvya; Benson R Kidenya; Rodrick Kabangila; Warren D Johnson; Daniel W Fitzgerald; Robert N Peck
Journal:  AIDS       Date:  2011-07-17       Impact factor: 4.177

3.  Renal epithelium is a previously unrecognized site of HIV-1 infection.

Authors:  Leslie A Bruggeman; Michael D Ross; Nozomu Tanji; Andrea Cara; Steven Dikman; Ronald E Gordon; Godfrey C Burns; Vivette D D'Agati; Jonathan A Winston; Mary E Klotman; Paul E Klotman
Journal:  J Am Soc Nephrol       Date:  2000-11       Impact factor: 10.121

4.  The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection.

Authors:  Lynda Anne Szczech; Samir K Gupta; Ramez Habash; Antonio Guasch; Robert Kalayjian; Richard Appel; Timothy A Fields; Laura P Svetkey; Katherine H Flanagan; Paul E Klotman; Jonathan A Winston
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

5.  The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy.

Authors:  Christina M Wyatt; Susan Morgello; Rebecca Katz-Malamed; Catherine Wei; Mary E Klotman; Paul E Klotman; Vivette D D'Agati
Journal:  Kidney Int       Date:  2008-12-03       Impact factor: 10.612

6.  HIV viremia and changes in kidney function.

Authors:  Chris T Longenecker; Rebecca Scherzer; Peter Bacchetti; Cora E Lewis; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

7.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

8.  Chronic kidney disease in HIV infection: an urban epidemic.

Authors:  Christina M Wyatt; Jonathan A Winston; Carlos D Malvestutto; Dawn A Fishbein; Irina Barash; Alan J Cohen; Mary E Klotman; Paul E Klotman
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

9.  Racial differences in end-stage renal disease rates in HIV infection versus diabetes.

Authors:  Andy I Choi; Rudolph A Rodriguez; Peter Bacchetti; Daniel Bertenthal; Paul A Volberding; Ann M O'Hare
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

10.  ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death.

Authors:  Siqin Zhaorigetu; Guanghua Wan; Ramesh Kaini; Zeyu Jiang; Chien-an A Hu
Journal:  Autophagy       Date:  2008-11-23       Impact factor: 16.016

View more
  1 in total

1.  Impaired Urine Dilution Capability in HIV Stable Patients.

Authors:  Waldo H Belloso; Mariana de Paz Sierra; Matilde Navarro; Marisa L Sanchez; Ariel G Perelsztein; Carlos G Musso
Journal:  Int J Nephrol       Date:  2014-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.